#A.G. Diagnostics | Explore Tumblr posts and blogs

agdiagnostics · 11 months ago

Text

A.G. Diagnostics: Setting the Standard as the Best Pathology Lab in Pune

A.G. Diagnostics, led by Dr. Awanti Golwilkar and Dr. Vinanti Golwilkar, is the best pathology lab in Pune, epitomizing precision and excellence. With a state-of-the-art 16000 sq. ft laboratory, cutting-edge technology, and a skilled team, the lab ensures accurate diagnoses. Accredited by NABL, it boasts a 40-year legacy, transparent practices, perpetual services, and a customer-centric approach, making it a trusted beacon of healthcare excellence in Pune.

#A.G. Diagnostics #pathology lab #Pathology Lab in Pune

0 notes

researchinsights24 · 10 months ago

Text

Preeclampsia Diagnostics Market to Witness High Growth

Preeclampsia is a pregnancy complication characterized by high blood pressure. It usually begins after 20 weeks of pregnancy in a woman whose blood pressure had been normal. If left untreated, preeclampsia can worsen to become a life-threatening condition for both mother and baby called eclampsia. Preeclampsia requires constant monitoring and diagnosis to prevent risks. Diagnosis involves regular checks of blood pressure and protein levels in urine tests. Other tests done are liver and kidney function tests and platelet counts. The global preeclampsia diagnostics market is estimated to be valued at US$ 1587.53 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics The global preeclampsia diagnostics market is driven by the increasing incidence of preeclampsia owing to rising risk factors like obesity, diabetes, and high blood pressure in women of reproductive age. According to World Health Organization (WHO), preeclampsia and related hypertensive disorders complicate approximately 10% of all pregnancies worldwide. Early diagnosis is very important to prevent adverse outcomes in both mother and infant. This is encouraging the development and adoption of novel diagnostic tests with improved accuracy and faster results. However, low awareness about preeclampsia symptoms in low and middle-income countries continues to limit the market growth. SWOT Analysis Strength: Preeclampsia diagnostics market is expected to witness significant growth owing to increasing prevalence of preeclampsia among pregnant women globally. Advances in diagnostic technologies enables early detection of the condition is a major strength boosting market growth. Further, growing awareness about preeclampsia and availability of various diagnostic tests aids in early identification of the condition. Weakness: High costs associated with advanced diagnostic technologies limits its adoption in low and middle income countries. Lack of skilled healthcare professionals to operate advanced diagnostic systems poses challenges especially in remote areas. Opportunity: Untapped developing markets in Asia Pacific and Latin America provides lucrative growth opportunities for market players. Also, ongoing R&D towards development of novel diagnostic tests with higher sensitivity and specificity offers growth prospects. Further, favorable government initiatives aimed at improving maternal health present opportunities. Threats: Stringent regulatory approval process for new diagnostic tests extends time to market and delays revenue generation. Lack of clinical evidence also limits adoption of newer tests. Further, reimbursement issues in some regions negatively impacts the market. Key Takeaways The Global Preeclampsia Diagnostics Market Size is expected to witness high growth.

Regional Analysis: North America is currently the largest as well as the fastest growing regional market. Factors such as high healthcare expenditure, availability of advanced diagnostic technologies, and presence of leading market players drives the North America market. The Asia Pacific market is poised to grow at a robust pace during the forecast period. Rapidly developing healthcare infrastructure, rising medical tourism, growing penetration of advanced diagnostic technologies, and expanding target patient population majorly fuels the Asia Pacific market for preeclampsia diagnostics. Key players operating in the preeclampsia diagnostics market are The Dow Chemical Company, BASF SE, Covestro A.G., Huntsman Corp., Eastman Chemical Co., Mitsui Chemicals Inc, Recticel S.A., RTP Company Inc., Lubrizol Corp., Rampf Holding GmbH & Co. KG.

For More Insights, Read: https://www.newsstatix.com/preeclampsia-diagnostics-market-trends-growth-and-regional-outlook-2023-2030/ Related Reports: https://masstamilan.in/emerging-role-of-biosensors-in-healthcare-advancing-disease-diagnosis-and-treatment-monitoring/

1 note · View note

rohans18 · 1 year ago

Text

Dental Intraoral Scanners Market Demands, Analysis, Size, Trends, Revenue by 2029

Global Dental Intraoral Scanners Market, By Brand (CEREC, iTero, TRIOS, i500, CS, Virtuo Vivo, and Others), Modality (Benchtop, Standalone, Wall Mounted, and Portable), Technology (Optical Wand and Confocal Microscope Imaging), Application (Dental Restoration, Orthodontics, Periodontics, Endodontics, and Others), Type (Powder-Free and Powder-Based), End User (Dental Hospitals and Clinics, Dental Diagnostic Centers and Dental Academic and Research Institutes, and Others), Distribution Channel (Retail Sales and Direct Tender) - Industry Trends and Forecast to 2030.

In the consistent Dental Intraoral Scanners market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Dental Intraoral Scanners industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential Dental Intraoral Scanners market report brings precise and exact market research information that drives business into the right direction.

Key Players

Some of the major players operating in the global dental intraoral scanners market are Dentsply Sirona (U.S.), Carestream Dental LLC (Georgia), PLANMECA OY (Finland), Align Technology, Inc. (U.S.), Medit Corp. (South Korea), 3Shape A/S. (Denmark), Acteon Group Ltd. (U.K.), 3DISC (U.S.), Owandy Radiology (France), Guangdong Launca Medical Device Technology Co., Ltd (China), Midmark Corporation. (U.S.), ASAHIROENTGEN IND.CO., LTD (Japan), DURR DENTAL SE (Germany), Denterprise International (U.S.), Shining3D (China), Condor (Belgium), GC EUROPE A.G. (Belgium), Apixia Corp. (U.S.), Institut Straumann AG (Switzerland), VATECH (South Korea) and Ningbo Runyes Medical Instrument Co., Ltd. among others.

Browse More Info @ https://www.databridgemarketresearch.com/reports/global-dental-intraoral-scanners-market

The research studies entailed in the winning Dental Intraoral Scanners market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Dental Intraoral Scanners Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

0 notes

impossibledeanmakerwombat · 2 years ago

Text

Automated Breast Ultrasound Systems Market Current Scenario Trends, Comprehensive Analysis and Regional Forecast 2021 to 2031

Rising prevalence of breast cancer across the globe and increasing government initiatives undertaken to encourage breast cancer awareness have significantly fuelled the demand for automated breast ultrasound system, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated breast ultrasound system market is slated to grow at approximately 10% CAGR over the forthcoming decade.

Key manufacturers are actively focusing on developing faster, accurate and minimal invasive ultrasound breast imaging system. According to report published in National Library of Medicine, integration of mammography with automated breast ultrasound system increased the sensitivity of the system to 99.1%.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-606

The combination drastically improves cancer detection rate among dense breasted women and reduces the interpretation time. Prominent manufacturer GE Healthcare launched a new automated breast ultrasound system named “Invenia” in U.S in October 2018. The main function of the system is to identify the presence of mammographically occult cancer especially in women with dense tissues.

With various other developments on cards, the automated breast ultrasound system market is expected to showcase impressive growth between 2021 and 2031.

“Visibly rising consumer inclination towards radiation free imaging and diagnostics systems is likely to intensify sales of automated breast ultrasound system among diagnostics laboratories,” says the FMI analyst.

Key Takeaways from FMI’s Automated Breast Ultrasound Systems Market Study

Increasing government investment to promote breast cancer awareness among women will bolster demand across the U.S.

The U.K is expected to experience noteworthy growth as governments and private organizations aim at curbing high mortality rate due to breast cancer.

Presence of modern healthcare infrastructure will increase automated breast ultrasound system adoption across Germany

Saudi Arabia will offer lucrative opportunities owing to rapid urbanization and emergence of advance diagnostics centers.

India is expected to exhibit increasing demand owing to increase in per capita income and to growing incidence of breast cancer among women.

Hospitals are expected to lead the market driven by faster accessibility modern tool and availability of skilled professionals.

Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-606

Competitive Landscape

GE Electric Co., Siemens A.G., Hitachi Ltd., SonoCiné Inc., Koninklijke are some prominent players operating in the automated breast ultrasound system market. They are focusing on improving the accuracy of automated breast ultrasound system for faster assessment of cancer screening in addition to getting government approval for their products.

For instance, Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring image of the complete breast.

Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.

More Insights on the Global Automated Breast Ultrasound Systems Market

In its latest report, FMI offers an unbiased analysis of the global automated breast ultrasound system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of end user (hospitals, diagnostic imaging laboratories), across seven major regions (North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific excluding Japan, and Middle East & Africa)

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-606

Key Segments Covered

By End User

Hospitals

Diagnostic Imaging Laboratories

America

Brazil

Mexico

Argentina

Rest of Latin America

Western Europe

EU-5

BENELUX (Belgium, Netherlands, Luxembourg)

NORDIC (Denmark, Finland, Iceland, Norway, Sweden)

Rest of Europe

Eastern Europe

Poland

Russia

Rest of Eastern Europe

Japan

APEJ (Asia Pacific excluding Japan)

China

India

ASEAN Countries

Australia & New Zealand

Rest of APEJ

MEA

GCC Countries

South Africa

Israel

Turkey

Iran

Rest of Middle East & Africa

Full Report @ https://www.futuremarketinsights.com/reports/automated-breast-ultrasound-system-market

0 notes

mobilexray-blog · 5 years ago

Text

Mobile X-Ray Services in Chennai

WELCOME TO A.G. MOBILE X-RAYS

As a frontrunner in providing high-end imaging solutions, we have been gaining prominence in the diagnostic field. We provide Best Mobile x-ray services in Chennai and around the city. We have the most sophisticated imaging equipment in-house, making us the one-stop destination for the very best in diagnostics. As we throw light into the world of Clarity, we welcome you to get an insight into imaging technology and discover what makes us an icon in the diagnostic field.

WE ARE HERE TO PROVIDE MOBILE X-RAYS!

AG mobile X-ray Services in Chennai was started at Chennai with its main office being located at Mylapore. For the past 20 years, we have been providing the best quality imaging services in and around the city. There are best quality radiographers actively working 24×7 with our firm. We also have the best radiologist for high standard diagnosis.

Home Visit Available

X-rays are usually performed either in the diagnostic center or in hospitals. For patients who are bedridden or cannot be transported to the hospital, we have a House visit facility for X-rays for treatment of the patient at an affordable cost.

#Mobile X-Ray Services in Chennai

1 note · View note

starfriday · 2 years ago

Text

D Y Patil International School, Worli hosts Career Fair to help students & parents explore global opportunities

17th September 2022: Aiming to showcase the global quality educational opportunities to the Indian students and their parents, D Y Patil International School, Worli hosted the DYPIS Career Fair 2022 at St. Regis, Lower Parel, Mumbai on 17th September 2022. Seeing a whopping 40+ domestic and international exhibiting institutes and universities, the fair was aimed to inform students of age 15-18 years about the state-of-the-art educational courses in India, United Kingdom, United States of America, Canada, Australia, New Zealand, as well as European nations such as Switzerland, Ireland, Germany, Spain, and France.

During the day-long event, the visiting students and parents also had the chance of listening to expert advice on selecting the right course and the appropriate location, to attain an illustrious career post the course completion. A panel discussion involving industry experts and a series of Break Out Sessions were curated mindfully throughout the event for a comprehensive knowledge and information exchange.

The IBDP students of D Y Patil International School, Worli moderated the Panel Discussion ‘India as an Emerging Superpower’ which marked the presence of Dr. Ajeenkya D Y Patil (Chairman, D Y Patil Group, Chancellor of Ajeenkya D Y Patil University, and Pro-chancellor of Dr. D. Y. Patil University), Dr. Pratibha Jain (Founder, Eduabroad Consulting), Dr. Awanti Golwilkar-Mehendale (Founder, A.G Diagnostics Pvt. Ltd.), Mr. Arun Tiwari (Chairman, IndusInd Bank Ltd) and Mr. Sandeep Ghosh (Group Country Manager- India & South Asia, Visa). The panelists voiced their experiences and thoughts about the emerging job market in India wherein most multinational companies are dependent on the talent here and are hence setting up massive offices here owing to the potential. They also spoke about how digitization has led to the creation of more jobs and has aided the country’s economy to thrive, hence paving its way to becoming an emerging superpower. Manager- India & South Asia, Visa). The panelists voiced their experiences and thoughts about the emerging job market in India wherein most multinational companies are dependent on the talent here and are hence setting up massive offices here owing to the potential. They also spoke about how digitization has led to the creation of more jobs and has aided the country’s economy to thrive, hence paving its way to becoming an emerging superpower. The break-out sessions, namely - India vs Abroad by Dr. Pratibha Jain (Founder, Eduabroad Consulting); New Age Entrepreneurship by Mr. Pavan Allena (Founder and CEO, Metamorphosis); and Basics of Podcasting and Use of Communication - by Hamza Chitalwalla (Podcast creator ‘Out of the Hood’) touched upon the changing dynamics of how futuristic talent to innovation are now increasingly being found in India over abroad; the new ways to enter and sustain as an entrepreneur in the digital age; and importance of the evolving concept of engaging masses through Podcast and how to use Communication better in the virtual world.

Speaking at the forum, Dr. Ajeenkya D Y Patil said, Indian students are increasingly looking at attaining global working skills and exposure ahead of starting their professional journey. Simplifying their quest to find the best college and location for their customized need, we at D Y Patil International School, Worli aimed at bringing the globally recognized, quality education providing domestic and international institutes under one roof at our DYPIS Career Fair 2022. The exhilarating experience at the fair was one of its kind as it provided grounds for meaningful conversations, power-packed networking opportunities, and immersive knowledge exchange.”

0 notes

leftcomputerpost · 3 years ago

Text

Automated Breast Ultrasound System Market to Garner Brimming Revenues by 2031

Rising prevalence of breast cancer across the globe and increasing government initiatives undertaken to encourage breast cancer awareness have significantly fuelled the demand for automated breast ultrasound system, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated breast ultrasound system market is slated to grow at approximately 10% CAGR over the upcoming decade.

Key manufacturers are actively focusing on developing faster, accurate and minimal invasive ultrasound breast imaging system. According to report published in National Library of Medicine, integration of mammography with automated breast ultrasound system increased the sensitivity of the system to 99.1%.

The combination drastically improves cancer detection rate among dense breasted women and reduces the interpretation time. Prominent manufacturer GE Healthcare launched a new automated breast ultrasound system named “Invenia” in U.S in October 2018. The main function of the system is to identify the presence of mammographically occult cancer especially in women with dense tissues.

With various other developments on cards, the automated breast ultrasound system market is expected to showcase impressive growth between 2021 and 2031.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-606

Key Takeaways from FMI’s Automated Breast Ultrasound Systems Market Study

Increasing government investment to promote breast cancer awareness among women will bolster demand across the U.S.

The U.K is expected to experience noteworthy growth as governments and private organizations aim at curbing high mortality rate due to breast cancer.

Presence of modern healthcare infrastructure will increase automated breast ultrasound system adoption across Germany

Saudi Arabia will offer lucrative opportunities owing to rapid urbanization and emergence of advance diagnostics centers.

India is expected to exhibit increasing demand owing to increase in per capita income and to growing incidence of breast cancer among women.

Hospitals are expected to lead the market driven by faster accessibility modern tool and availability of skilled professionals.

Competitive Landscape

GE Electric Co., Siemens A.G., Hitachi Ltd., SonoCiné Inc., Koninklijke are some prominent players operating in the automated breast ultrasound system market. They are focusing on improving the accuracy of automated breast ultrasound system for faster assessment of cancer screening in addition to getting government approval for their products.

For instance, Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring image of the complete breast.

Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-606

More Insights on the Global Automated Breast Ultrasound Systems Market

In its latest report, FMI offers an unbiased analysis of the global automated breast ultrasound system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of end user (hospitals, diagnostic imaging laboratories), across seven major regions (North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific excluding Japan, and Middle East & Africa)

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: [email protected] For Media Enquiries: [email protected] Website: https://www.futuremarketinsights.com

0 notes

1188ps · 3 years ago

Text

Immunohistochemistry Market Covid-19 Impact Analysis, Share, Size, Leading Players, Industry Growth And Forecast 2027

Immunohistochemistry Market Overview:

The Immunohistochemistry Market Size Analysis, 2021 market research report is in-depth, giving you all the information you need to make informed industry decisions and develop strategic growth plans. Regardless of the production method or cost structures, this report provides a full understanding of advanced tactics and plans.

The study covers the Immunohistochemistry market's most recent revenue and market trends. It stresses a market overview, definition, and structure, as well as preventative and pre-planned management. The report focuses on the factors that influence the Immunohistochemistry Market, such as gross margin, cost, market share, capacity utilisation, and supply. It also aids in determining the future potential of Immunohistochemistry Market in the next years. The report presents a market overview through common subjects that are highlighted with unique data based on the need. This overview aids in making decisions about how to approach the market and comprehending the industry's backdrop.

Request for free sample: https://www.maximizemarketresearch.com/request-sample/29312

Market Scope:

The research examines the most important market trends and how they will affect new business investments and development in general. New technology, foreign entry, new rules, government investment, new uses, and other industry dynamics are all influenced by market trends. This study includes a detailed trend analysis to assist you in making educated industry decisions in the Immunohistochemistry market.

The Immunohistochemistry Industry 2021 Market Research Report provides exclusive key statistics, facts, information, trends, and competitive landscape insights in this particular field. The current situation of the Immunohistochemistry market is examined, and the market is forecasted till 2027. Company profiles, product images and specs, capacity, production, price, cost, revenue, and contact information for global leading manufacturers of Immunohistochemistry market share are likely to be included in the study. Raw materials and equipment are also available.

Get more Report Details: https://www.maximizemarketresearch.com/market-report/global-immunohistochemistry-market/29312/

Key players:

• F. Hoffmann-LA Roche AG • Danaher Corporation • Agilent Technologies, Inc. • Thermo Fisher Scientific Inc. • Merck Millipore • Bio-Rad Laboratories, Inc. • Perkinelmer, Inc. • Abcam PLC • Cell Signaling Technology, Inc. • Bio SB • Shimadzu Corporation • Qiagen N.V. • PerkinElmer, Inc. • Abbott Diagnostics • Meridian Life Science, Inc. • SDIX, LLC • A.G. Scientific, Inc. • Gallus Immunotech, Inc. • Lonza Biologics Ltd. • Takara Bio, Inc. • Beckman Coulter, Inc. • Promega Corporation • BioMerieux • Wako Pure Chemical Industries Ltd. • Waters Corp.

The research report focuses on the current market size of the Immunohistochemistry market and their growth rates, based on records and financial information with a company profile of major players/manufacturers.

Regional analysis:

Regional Insights in our studies ensure that you are well-versed in the Immunohistochemistry market on a regional level. Any meaningful assessment of potential policy options in response to global market change requires a thorough understanding of local energy, economic, political, and geographic characteristics. The Immunohistochemistry market's operation has a substantial impact on local development plans. Our report allows us to conduct regional analyses while also accounting for the effects of Immunohistochemistry market and local growth in other places. At the regional, national, and international levels, we conduct a wide spectrum of high-resolution regional research. We also offer PESTAL and PORTAL analyses to help you better understand the Immunohistochemistry market in a certain region. Our study also includes company profiles from various regions, as well as information on their business strategies and statistics.

COVID-19 Impact Analysis on Immunohistochemistry Market:

The report has identified detailed impact of COVID-19 on Immunohistochemistry market in regions such as North America, Asia Pacific, Middle-East, Europe, and South America. The report provides Comprehensive analysis on alternatives, difficult conditions, and difficult scenarios of Immunohistochemistry market during this crisis. The report briefly elaborates the advantages as well as the difficulties in terms of finance and market growth attained during the COVID-19. In addition, report offers a set of concepts, which is expected to aid readers in deciding and planning a strategy for their business.

Key Questions answered in the Immunohistochemistry Market Report are:

Which product segment grabbed the largest share in the Immunohistochemistry market?

How is the competitive scenario of the Immunohistochemistry market?

Which are the key factors aiding the Immunohistochemistry market growth?

Which region holds the maximum share in the Immunohistochemistry market?

What will be the CAGR of the Immunohistochemistry market during the forecast period?

Which application segment emerged as the leading segment in the Immunohistochemistry market?

Which are the prominent players in the Immunohistochemistry market?

What key trends are likely to emerge in the Immunohistochemistry market in the coming years?

What will be the Immunohistochemistry market size by 2027?

Which company held the largest share in the Immunohistochemistry market?

About Us:

Maximize Market Research provides B2B and B2C research on 12000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defence and other manufacturing sectors.

Contact Us:

MAXIMIZE MARKET RESEARCH PVT. LTD.

3rd Floor, Navale IT Park Phase 2,

Pune Bangalore Highway,

Narhe, Pune, Maharashtra 411041, India.

Email: [email protected]

Phone No.: +91 20 6630 3320

Website: www.maximizemarketresearch.com

#Immunohistochemistry Market Research Immunohistochemistry Market Trends Immunohistochemistry Market Growth Immunohistochemistry Impact Covid

0 notes

healthcareandwellness-blog · 6 years ago

Link

Market Introduction

Ambulatory blood pressure monitors map the blood pressure of an individual on a daily basis. A digital blood pressure machine attached to a belt is strapped either on the arm or on the wrists. These devices are useful to check if the level of blood pressure of an individual is higher performing daily chores compared to the level mapped in a clinic, which is also known as a white coat effect. Ambulatory blood pressure monitors are used to check several types of conditions related to hypertensions such as episodic hypertension, autonomic hypertension, masked hypertension, and hypotensive symptoms caused due to antihypertensive medications among others.

Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/72

Rising number of people suffering from high and low blood pressure issues is greatly fueling the market growth of ambulatory blood pressure monitors. According to the World Heart Federation, high blood pressure, also called hypertension is the leading cause for strokes and it is greatly responsible for ischemic strokes and hemorrhagic stroke

Market Dynamics

Rising aging population across the globe is one of the key factors responsible for the growth of the ambulatory blood pressure monitors market. The aging population is highly susceptible to strokes and related cardiovascular diseases. According to United Nations, one in eight people across the globe were aged 60 and above in 2015 and by 2030, one in six people is expected to be above 60 years of age. Further, by 2050, one in five people is expected to be more than 60 years of age. According to Insights and Reports, approximately 70% of the strokes occur in people who aging over 60. According to Insights and Reports, U.S. witnesses more than 750,000 people suffering from strokes every year. It is listed as the 4th leading cause of death, resulting in more than 150,000 deaths in the country. Further, approximately 85% of the strokes are classified as ischemic. This has given rise to the demand for ambulatory blood pressure monitors in the country.

Further, rising demand for portable devices for monitoring blood pressure has become a trend among the populace including the young population. Unhealthy lifestyle which results from hectic work schedule, high consumption of fast food, and higher consumption tobacco and related products have created an awareness among the population regarding cardiovascular diseases that could lead to stroke. Keeping this into consideration, manufacturers operating in the electronics industry have begun to incorporate health monitoring features in smartphones and smart-watches as well. For instance, Omron Corporation, a key player in the medical devices industry, is expected to launch a smart-watch later this year called HeartGuide. This smart-watch is expected to monitor the blood pressure of an individual on a daily basis. The HeartGuide is also expected to feature an extra-stiff band similar to blood pressure cuff, which will inflate to take an oscillometric measurement. Further, the watch will also be programmed to take blood pressure readings during night time in order to measure the risk of stroke and hyper tension while sleeping. However, the product is undergoing clinical test and is expected to be submitted to the Food and Drug Administration (FDA) in the third quarter of 2018.These factors are responsible for the high growth of the ambulatory blood pressure monitors market at present.

Market Segmentation and Analysis

Based on product type, the global ambulatory blood pressure monitors market has been segmented into wrist bands, and arm bands among others. Wrist bands dominated the market in 2016 and is expected to retain its position throughout the forecast period.

Based on end-user the ambulatory blood pressure monitors market has been classified into hospitals, clinics and diagnostic centers, surgical centers and home care among others.

Geographical Outlook

North America led the global ambulatory blood pressure monitors market in 2016, followed by Europe. Rising prevalence of heart diseases, coupled with higher spending capacity for expensive medical devices are some of the factors pushing the market growth of ambulatory blood pressure monitors in the region. U.S. is spearheading the growth of the market in North America. According to Insights and Reports, more than 650,000 people die owing to cardiovascular diseases every year in the U.S. Further, healthcare spending per capita in the U.S amounted to US$ 10,554 in 2017. These factors are greatly pushing the market for ambulatory blood pressure monitors in the country.

According to Insights and Reports, Europe recorded more than 4.1 million deaths caused due to cardiovascular diseases in 2017, while more than 2 million deaths were recorded in the European Union. Deaths caused to ischemic heart diseases and strokes showed higher rates Central Europe and Eastern Europe.

For more information about this report @ https://www.insightsandreports.com/industry-reports/ambulatory-blood-pressure-monitors-market

Asia Pacific is anticipated to project the fastest growth during the forecast period with India, China and Japan being in the forefront for the growth of this industry. Strengthening economic conditions in China and India, increasing spending capacities on healthcare facilities coupled with rising government spending on healthcare facilities are some of the key factors fuelling the market growth of ambulatory blood pressure monitors.

Competitive Landscape

A & D Company Ltd., Spacelabs Healthcare Inc., Microlife A.G., Schiller A.G., Omron Corporation, General Electric, and SunTech Medical Inc. among others are some of the key players operating in the field of ambulatory blood pressure monitors market

1 note · View note

jesse-pinkman123 · 3 years ago

Text

Biopharmaceutical and Biomedicine Market Forecast Opportunity Analysis - 2025

Global Biopharmaceutical and Biomedicine Market, By Product Type (Biopharmaceutical, Nanomedicine, Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits), By Application (Therapeutics, Diagnostics, and Research and Development) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 358.4 Bn in 2016 and is projected to exhibit a CAGR of 9.4% over the forecast period (2017–2025). Frequent launches and approvals of novel biopharmaceutical products is expected to drive the market growth in the near future. In 2017, Sanofi S.A. received U.S. Food and Drug Administration (FDA) approval for Dupixent (dupilumab) injection to treat adults suffering from moderate to severe eczema (atopic dermatitis). In 2017, F. Hoffmann-La Roche AG received FDA approval for Hemlibra (emicizumab-kxwh), indicated to prevent and reduce bleeding incidents among children and adults suffering from haemophilia A with factor VIII inhibitors. In 2017, Novo Nordisk A/S received the U.S. FDA approval for REBINYN (Coagulation Factor IX (Recombinant), GlycoPEGylated) indicated for treatment and control of bleeding episodes, and perioperative management of bleeding among children and adults. In 2017, Novo Nordisk received U.S. FDA approval for Fiasp (Insulin aspart injection). Fiasp is a fast acting mealtime insulin, which is indicated to improve glycemic control among adults suffering from type 1 and type 2 diabetes. In 2017, Serum Institute of India launched its Rabishield, a rabies monoclonal antibody, developed in partnership with the University of Massachusetts Medical School. In 2017, Mundipharma GmbH launched its Truxima (rituximab), a biosimilar monoclonal antibody for the treatment of cancer, in the UK, Germany, Italy, the Netherlands, Belgium, Republic of Ireland, and Luxembourg, following authorization by the European Medicines Agency (EMA). The launches and approvals of such novel biopharmaceutical and biomedicine technologies is expected to create a conducive environment for growth of the global biopharmaceutical and biomedicine market.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/18

Browse 45 Market Data Tables and 42 Figures spread through 285 Pages and in-depth TOC on Biopharmaceutical and Biomedicine Market By Product Type (Biopharmaceutical, Nano medicine, Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits Market) and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2025

Strategic collaboration of key players and research institutes in the market for the development of biopharmaceutical and biomedicine technologies is also expected to positively affect the market growth. For instance, in February 2018, AbbVie Inc. and Voyager Therapeutics, Inc. entered into a strategic partnership for the development and commercialization of gene therapies for Alzheimer's disease and other neurodegenerative diseases. In February 2018, Kite Pharma, Inc., a Gilead Sciences, Inc. company, collaborated with Sangamo Therapeutics Inc. for developing engineered cell therapies to treat cancer. As per the agreement, Kite Pharma, Inc. will use Sangamo Therapeutics’ zinc finger nuclease (ZFN) gene-editing product type for developing next-generation ex vivo cell therapies for treatment of cancer. In 2017, The National Institutes of Health collaborated with 11 leading biopharmaceutical companies to boost the development of new cancer immunotherapy. The partners include AbbVie Inc., Amgen Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Bristol-Myers Squibb, Celgene Corporation, Genentech Inc., subsidiary of Roche Group, Gilead Sciences, Inc., GlaxoSmithKline Plc., Janssen Pharmaceutical Companies of Johnson & Johnson, Novartis A.G., and Pfizer, Inc. In 2017, AbCellera Biologics, Inc. collaborated with GlaxoSmithKline plc. for the discovery of monoclonal antibodies against an undisclosed membrane protein target.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/bio-pharmaceuticals-and-biomedicine-market-18

Key Takeaways of the Biopharmaceutical and Biomedicine Market:

The global biopharmaceutical and biomedicine market is expected to exhibit a CAGR of 9.4% over the forecast period (2017–2025), owing to increasing development of novel technologies and strategic collaboration of key players in the market for biopharmaceutical and biomedicine technologies

North America was the dominant region in the global biopharmaceutical and biomedicine market and is expected to retain its dominance over the forecast period (2017–2025). This is due to presence of major key players and increasing funding by various organizations to support biopharmaceutical researches. For instance, in 2015, National Institutes of Health (NIH) funded US$ 54 million to support emerging challenges in biomedical research. NIH has funded to launch four broad scientific Program: the Glycoscience Program, the 4D Nucleome Program, the Gabriella Miller Kids First Research Program, and the Science of Behavior Change Program.

Asia Pacific is expected to exhibit highest growth, with a CAGR of 15.3% over the forecast period, due to increasing research and development in China in biopharmaceutical and biomedicine. For instance, in 2016, Chinese scientists injected cells modified with the CRISPR-Cas9 gene-editing technology in human. This is the first time in world when researchers from the Sichuan University in Chengdu inserted re-engineered cells into a lung cancer patient participating in a clinical trial at the West China Hospital.

Major players operating in the biopharmaceutical and biomedicine market include Amgen Inc., F. Hoffmann-La Roche AG, Novartis AG, Johnson & Johnson, Pfizer, Inc., Sanofi S.A., Eli Lilly and Company, AbbVie Inc., Novo Nordisk A/S, Bristol - Myers Squibb, NanoString Technologies, Inc., Qiagen N.V., Celgene Corporation, and Affimed N.V.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/18

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:[email protected]

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

#Biopharmaceutical and Biomedicine Market Analysis #Biopharmaceutical and Biomedicine Market

0 notes

agdiagnostics · 1 month ago

Text

In the year 1978, Dr Ajit Golwilkar, dreamt of bringing world-class pathology services to the city of Pune and brought his pathology laboratory on Karve Road, called Golwilkar Laboratories to life. His name has been considered synonymous with quality laboratory services in Pune & the country for over four decades. To begin with, the samples used to test with the then available basic diagnostic techniques, nonetheless maintaining the highest accuracy and reliability. His endeavour had been to deliver results in the shortest possible time yet, at an affordable price.

#diagnosticscentrepune #diagnosticscentre #agdiagnostics

0 notes

anitakumarigrewal · 4 years ago

Text

Growth in Landscape of Europe Wireless Healthcare Market Outlook: Ken Research

The Wireless technology has its more obvious advantages. Several hospitals still rely on paper charts. By accepting the wireless technology doctors and nurses no longer have to track down a patient’s chart that may be inactive at the nurses’ station. Granting instant admittance to patient information instead of depending on manual charts not only saves time but can also outcome in saving a life. The usage of Personal Data Assistants (PDA ‘s) enable the doctors and nurses to apprise patient information automatically so that anyone tracking the advancement of a patient will have up-to-date admittance to vital information. Additionally, when a doctor enters a process or schedule on a patient’s chart, the billing system will apprise with the correct records aiding to more specific care and enabling for less billing errors. Transforming the way patient information is stored, shared, and retrieved grants a speedier response time for speedily treatment so that staff can service more patients in a given time duration.

According to the report analysis, ‘Europe Wireless Healthcare Market 2020-2026 by Component, Device, Technology, Application, End User, and Country: Trend Forecast and Growth Opportunity’ states that Aerohive Networks, Inc., Alcatel-Lucent, Allscripts Healthcare Solutions, Inc., Apple, Inc., AT&T, Inc., Cerner Corporation, Cisco Systems, Inc., GE Healthcare, Mckesson Corporation, Motorola Solutions, Inc., Nihon Kohden Corporation, Omron Corporation, Philips Healthcare, Polar Electro Inc., Qualcomm, Inc., Samsung Electronics Co. Ltd, Siemens A.G., Verizon Communications, Inc., and Vocera Communication, Inc. are the organized players which effectively performing in Europe Wireless Healthcare market for leading the highest market growth and registering the great value of market share around the Europe during the forthcoming duration while establishing the several research and development programs, analysing the strategies and policies of the government as well as companies, delivering the better consumer satisfaction, recruiting the great and intellectual personnel, advancing the qualitative as well as quantitative measures, decreasing the linked prices, spreading the awareness connected to such, and implementing the policies and strategies of profit making and enlargements.

The penetration of internet and wireless communication technology is propelling the market studied. In a connected hospital, caregivers usage wireless medical equipment to deliver the best quality of care to patients, rather than being inattentive by time-overwhelming administrative tasks. Doctors and nurses can conveniently access up-to-date patient information, allowing the treatment decisions assisted by real-time medical information, thus, resulting in developed the outcomes for patients.

Wearable devices for continuous observing are driving the market. Owing to the propagation of Smartphone and the acceptance of wearable devices, medical device and diagnostic centres are observing with the body-worn sensors that can monitor vital signs and communicate them in real time to an online podium that can be remotely retrieved.

Ever changing trend toward value-based care is another aspect contributing to the growth of the wireless health market. At present, few of the telehealth services, such as consulting a doctor via video connection, are compensated by CMS. The usage of digital services such as several platforms for health management has encouraged the development of several applications for managing diabetes, heart diseases, and asthma. The usage of applications for chronic disease management, fitness tracking, supporting medication adherence, safeguarding hospital readmissions, symptom tracking, and managing mental and behavioural health are on the growth.

For More Information, click on the link below:-

Europe Wireless Healthcare Market Research Report

Related Report:-

Global Wireless Healthcare Market 2020-2026 by Component, Device, Technology, Application, End User, and Region: Trend Forecast and Growth Opportunity

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

[email protected]

+91-9015378249

#Europe Wireless Healthcare Market

0 notes

techsciresearch · 4 years ago

Text

Contrast Media Injectors Market to grow at an Impressive CAGR During the Forecast Period | TechSci Research

Global Contrast Media Injectors Market is anticipated to grow on the backbone of technological advancements in the medical devices.

According to TechSci Research report, “Global Contrast Media Injectors Market By Product (Injector Systems v/s Consumables) By Injector Type (Single-head, Dual-head, Syringeless) By Application (Radiology, Interventional Cardiology, Others) By End User (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers) By Region, Competition Forecast & Opportunities, 2026”, the global contrast media injectors market is anticipated to grow in the forecast period from 2022 to 2026. Facts like IT enabled solutions for syringeless, dual-head, and automated injectors are expected to drive the market growth with an impressive CAGR in upcoming five years. Syringeless injectors are easier to use, and quite efficient. It allows to avoid the contrast agent wastage that may arise otherwise, also it provides contrast enhancement during imaging. Diagnostics require contrast media injectors to enhance blood and perfusion in tissues, and other processes to identify the issues. These processes were earlier carried out through invasive surgeries. Increased preference by patients for non-invasive, or minimally invasive procedures is driving the growth of global contrast media injectors market in next five years.

Moreover, surge in demand for non-invasive and minimally invasive surgery procedures is driving the growth of global contrast media injectors market in the forecast period. The process provides various perks over the main-line surgery procedures like, smaller incisions, rapid wound healing, shorter hospital stays, less pain, and minor surgical wounds. Procedures conducted with the contrast media injectors provide high quality, and real time imaging for the diagnostic or surgical procedures that creates a convenient opportunity for the surgeons allowing them to perform the surgery at the appropriate area. This factor is one of the major factors that is actively driving the global contrast media injector market growth in next five years.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Contrast media injectors Market"

https://www.techsciresearch.com/report/contrast-media-injectors-market/7366.html

The global contrast media injectors market is segmented on the basis of product, injector type, application, end user, regional distribution, and competitional landscape. Based on the injector type, the market is further categorized into single-head, dual-head, and syringeless. Single-head injector segment is anticipated to assert its dominance over the market in the forecast years. The wide range of usage of single-head injector as in angiography, CT, and MRI, drives the growth of the market segment. Moreover, single-head injectors are more cost effective than its competitor injector systems.

Thus, these products are more preferred in the developing nations like India, China, and Brazil.

Based on end user, the market is bifurcated into hospitals & clinics, ambulatory care centers, and diagnostic centers. Hospitals and clinics hold the largest market share and is expected to dominate the market segment owing to the increasing number of patients being admitted for the target diseases like cancer, cardiovascular disorders, and neurological disorders. Radiology department in the hospitals have the wide range of applications of contrast media injectors thereby driving the growth of the market segment. With the number of patients turnaround and readmissions in the hospitals the segment can well versed be said that it is anticipated to dominate the market in upcoming five years.

Some of the major competitors in the market are Bracco Imaging S.P.A, Bayer A.G., Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd, Sino Medical-Device Technology Co., Ltd. (Sinomdt), APOLLO RT Co. Ltd., Shenzhen Anke High-tech Co. Ltd, Shenzen Seacrown Electromechanical Co Ltd., Medtron AG, among others. With technical advancements in the contrast media injectors, the market is anticipated to grow. Top players with their elaborative research and development of more efficient devices would drive the growth of the market. These activities along with partnerships and alliances would benefit the competitors to stabilize their market share.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7366

Customers can also request for 10% free customization on this report.

“Radiology involves the maximum application of the contrast media injectors for the early and feasible detection of carcinogenic cells, cardiovascular diseases, heart conditions, breast cancer, broken bones, gastrointestinal conditions, and blood clots in the veins. The life threatening diseases often involves elaborative and prolonged surgeries, if diagnostics and other surgical procedures can be conducted in a non-invasive or minimally invasive process, it is a beneficial factor for the patient and eradicates the chances of post-surgery complications. North American region may dominate the market owing to its excellent healthcare facility although European region with several major players of the market would have significant revenue share too,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Contrast Media Injectors Market By Product (Injector Systems v/s Consumables) By Injector Type (Single-head, Dual-head, Syringeless) By Application (Radiology, Interventional Cardiology, Others) By End User (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of Global Contrast media injectors and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Contrast media injectors.

Browse Related Reports:

Global Diagnostic Imaging Market By Product Type ( Architecture (Open/Closed), By Field Strength (High and Very-High Field MRI Systems), By Systems (Ultrasound Systems, Nuclear Imaging Systems, X-Ray Imaging Systems, CT Scanner, MRI System, Mammography System, Fluoroscopy), By Portability (Stationary, Portability), By Application (OB/Gyn, Orthopaedic, Musculosekeletal, Neuro &Spine, General Imaging, Cardio & Thoracic, Breast health, Others), By End Users (Hospitals, Diagnostic Imaging Centers, Others), By Region, Forecast & Opportunities, 2016-2026F

https://www.techsciresearch.com/report/diagnostic-imaging-market/4634.html

Global Bleeding Disorders Drugs Market By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By Gender (Male v/s Female), By End User (Hospitals, Hemophilia Treatment Centers, Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/bleeding-disorders-drugs-market/7331.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

#TechSci #Market Research Reports #Global Contrast Media Injectors Market #Contrast Media Injectors Market #Contrast Media Injectors Market Size #healthcare robotics market size #Contrast Media Injectors Market Forecast #healthcare

0 notes

techscimarketresearch · 4 years ago

Text

Contrast Media Injectors Market to grow at an Impressive CAGR During the Forecast Period | TechSci Research

Global Contrast Media Injectors Market is anticipated to grow on the backbone of technological advancements in the medical devices.